Achievement of Three Year Remission with Bevacizumab and Irinotecan in Recurrent Glioblastoma Multiforme: A case Report

Achievement of Three Year Remission with Bevacizumab and Irinotecan in Recurrent Glioblastoma Multiforme: A case Report

A 34-year-old man presented to the hospital with right-sided headache. He was diagnosed with GBM. He underwent resection of the tumor with placement of carmustine impregnated wafers. Then he underwent adjuvant chemotherapy with temozolamide. Before the completion of chemotherapy he had a recurrence....

Full description

Bibliographic Details
Main Authors: Abhirami Vivekanandarajah, Balakumar Krishnarasa, Mervat Mourad, Nelly Aoun, Marcel Odaimi
Format: Article
Language:English
Published: SAGE Publishing 2011-01-01
Series:Clinical Medicine Insights: Oncology
Online Access:https://doi.org/10.4137/CMO.S6525
id doaj-75c730283abe47f0ba36958daaea8ac5
record_format Article
spelling doaj-75c730283abe47f0ba36958daaea8ac52020-11-25T02:37:14ZengSAGE PublishingClinical Medicine Insights: Oncology1179-55492011-01-01510.4137/CMO.S6525Achievement of Three Year Remission with Bevacizumab and Irinotecan in Recurrent Glioblastoma Multiforme: A case ReportAbhirami Vivekanandarajah0Balakumar Krishnarasa1Mervat Mourad2Nelly Aoun3Marcel Odaimi4Staten Island University Hospital, 475 Seaview Avenue, Staten Island, New York 10305.Staten Island University Hospital, 475 Seaview Avenue, Staten Island, New York 10305.Staten Island University Hospital, 475 Seaview Avenue, Staten Island, New York 10305.Staten Island University Hospital, 475 Seaview Avenue, Staten Island, New York 10305.Staten Island University Hospital, 475 Seaview Avenue, Staten Island, New York 10305.A 34-year-old man presented to the hospital with right-sided headache. He was diagnosed with GBM. He underwent resection of the tumor with placement of carmustine impregnated wafers. Then he underwent adjuvant chemotherapy with temozolamide. Before the completion of chemotherapy he had a recurrence. He underwent re-resection with placement of carmustine impregnated wafers. Subsequently he had eighteen cycles of salvage biochemotherapy with bevacizumab and irinotecan. To date, routine MRI scans of the brain have not shown evidence of recurrence. He continues to be in remission three years after treatment with bevacizumab and irinotecan.https://doi.org/10.4137/CMO.S6525
collection DOAJ
language English
format Article
sources DOAJ
author Abhirami Vivekanandarajah
Balakumar Krishnarasa
Mervat Mourad
Nelly Aoun
Marcel Odaimi
spellingShingle Abhirami Vivekanandarajah
Balakumar Krishnarasa
Mervat Mourad
Nelly Aoun
Marcel Odaimi
Achievement of Three Year Remission with Bevacizumab and Irinotecan in Recurrent Glioblastoma Multiforme: A case Report
Clinical Medicine Insights: Oncology
author_facet Abhirami Vivekanandarajah
Balakumar Krishnarasa
Mervat Mourad
Nelly Aoun
Marcel Odaimi
author_sort Abhirami Vivekanandarajah
title Achievement of Three Year Remission with Bevacizumab and Irinotecan in Recurrent Glioblastoma Multiforme: A case Report
title_short Achievement of Three Year Remission with Bevacizumab and Irinotecan in Recurrent Glioblastoma Multiforme: A case Report
title_full Achievement of Three Year Remission with Bevacizumab and Irinotecan in Recurrent Glioblastoma Multiforme: A case Report
title_fullStr Achievement of Three Year Remission with Bevacizumab and Irinotecan in Recurrent Glioblastoma Multiforme: A case Report
title_full_unstemmed Achievement of Three Year Remission with Bevacizumab and Irinotecan in Recurrent Glioblastoma Multiforme: A case Report
title_sort achievement of three year remission with bevacizumab and irinotecan in recurrent glioblastoma multiforme: a case report
publisher SAGE Publishing
series Clinical Medicine Insights: Oncology
issn 1179-5549
publishDate 2011-01-01
description A 34-year-old man presented to the hospital with right-sided headache. He was diagnosed with GBM. He underwent resection of the tumor with placement of carmustine impregnated wafers. Then he underwent adjuvant chemotherapy with temozolamide. Before the completion of chemotherapy he had a recurrence. He underwent re-resection with placement of carmustine impregnated wafers. Subsequently he had eighteen cycles of salvage biochemotherapy with bevacizumab and irinotecan. To date, routine MRI scans of the brain have not shown evidence of recurrence. He continues to be in remission three years after treatment with bevacizumab and irinotecan.
url https://doi.org/10.4137/CMO.S6525
work_keys_str_mv AT abhiramivivekanandarajah achievementofthreeyearremissionwithbevacizumabandirinotecaninrecurrentglioblastomamultiformeacasereport
AT balakumarkrishnarasa achievementofthreeyearremissionwithbevacizumabandirinotecaninrecurrentglioblastomamultiformeacasereport
AT mervatmourad achievementofthreeyearremissionwithbevacizumabandirinotecaninrecurrentglioblastomamultiformeacasereport
AT nellyaoun achievementofthreeyearremissionwithbevacizumabandirinotecaninrecurrentglioblastomamultiformeacasereport
AT marcelodaimi achievementofthreeyearremissionwithbevacizumabandirinotecaninrecurrentglioblastomamultiformeacasereport
_version_ 1724795929490358272

Similar Items